Switch Strategy From Etravirine (ETR) to Doravirine (DOR) in Virologically-Suppressed HIV-1 Infected Adults With ETR-Resistance

Clinical trial NCT05506605 · UNKNOWN

Trial details

NCT number: NCT05506605
Sponsor: Fundacion Clinic per a la Recerca Biomédica
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2022-12-12
Primary completion: 2024-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.